Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis

Overview

Journal J Clin Med

Specialty General Medicine

Date 2019 May 1

PMID 31035618

Citations 3

Authors

Tomas Smutny

Ivan Barvik

Tomas Veleta

Petr Pavek

Tomas Soukup

Affiliations

Soon will be listed here.

Abstract

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are closely related chronic inflammatory diseases. Glucocorticoids (GCs) are first-choice drugs for PMR and GCA, although some patients show poor responsiveness to the initial GC regimen or experience flares after GC tapering. To date, no valid biomarkers have been found to predict which patients are at most risk for developing GC resistance. In this review, we summarize PMR- and GCA-related gene polymorphisms and we associate these gene variants with GC resistance and therapeutic outcomes. A limited number of GC resistance associated-polymorphisms have been published so far, mostly related to allele. Other genes such , and , , and may play a role, although discrepancies are often found among different populations. We conclude that more studies are required to identify reliable biomarkers of GC resistance. Such biomarkers could help distinguish non-responders from responders to GC treatment, with concomitant consequences for therapeutic strategy.

Citing Articles

Clinical, Serological, and Immunological Characteristics of Greek Patients with Polymyalgia Rheumatica and/or Giant Cell Arteritis: A Research Protocol.

Memi T, Koletsos N, Gerolymatou N, Karakosta M, Georgiadis A, Drosos A Mediterr J Rheumatol. 2024; 34(4):577-580.

PMID: 38282939 PMC: 10815527. DOI: 10.31138/mjr.050923.csa.

Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study.

Quartuccio L, Isola M, Bruno D, Treppo E, Gigante L, Angelotti F J Transl Autoimmun. 2020; 3:100072.

PMID: 33305250 PMC: 7718148. DOI: 10.1016/j.jtauto.2020.100072.

Current State of Precision Medicine in Primary Systemic Vasculitides.

Demirkaya E, Arici Z, Romano M, Berard R, Aksentijevich I Front Immunol. 2020; 10:2813.

PMID: 31921111 PMC: 6927998. DOI: 10.3389/fimmu.2019.02813.

References

Weyand C, Fulbright J, Evans J, Hunder G, Goronzy J . Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med. 1999; 159(6):577-84. DOI: 10.1001/archinte.159.6.577. View

Salvarani C, Boiardi L, Mantovani V, Ranzi A, Cantini F, Olivieri I . HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity. Ann Rheum Dis. 1999; 58(5):303-8. PMC: 1752874. DOI: 10.1136/ard.58.5.303. View

Narvaez J, Nolla-Sole J, Clavaguera M, Valverde-Garcia J, Roig-Escofet D . Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis. J Rheumatol. 1999; 26(9):1945-52. View

Salvarani C, Boiardi L, Mantovani V, Ranzi A, Cantini F, Olivieri I . HLA-DRB1, DQA1, and DQB1 alleles associated with giant cell arteritis in northern Italy. J Rheumatol. 1999; 26(11):2395-9. View

Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D . Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J Rheumatol. 2000; 27(5):1215-21. View

Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L . Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum. 2000; 30(1):17-24. DOI: 10.1053/sarh.2000.8366. View

Salvarani C, Boiardi L, Timms J, Silvestri T, Ranzi A, Macchioni P . Absence of the association with CC chemokine receptor 5 polymorphism in polymyalgia rheumatica. Clin Exp Rheumatol. 2000; 18(5):591-5. View

Meliconi R, Pulsatelli L, Dolzani P, Boiardi L, Macchioni P, Salvarani C . Vascular endothelial growth factor production in polymyalgia rheumatica. Arthritis Rheum. 2000; 43(11):2472-80. DOI: 10.1002/1529-0131(200011)43:11<2472::AID-ANR14>3.0.CO;2-B. View

Boiardi L, Salvarani C, Timms J, Silvestri T, Macchioni P, Di Giovine F . Interleukin-1 cluster and tumor necrosis factor-alpha gene polymorphisms in polymyalgia rheumatica. Clin Exp Rheumatol. 2001; 18(6):675-81. View

10.

Gonzalez-Gay M, Hajeer A, Dababneh A, Makki R, Garcia-Porrua C, Thomson W . Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association. J Rheumatol. 2001; 28(1):122-5. View

11.

Amoli M, Shelley E, Mattey D, Garcia-Porrua C, Thomson W, Hajeer A . Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis. J Rheumatol. 2001; 28(7):1600-4. View

12.

Amoli M, Shelley E, Mattey D, Garcia-Porrua C, Thomson W, Hajeer A . Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica. J Rheumatol. 2002; 29(3):502-4. View

13.

Gonzalez-Gay M, Hajeer A, Dababneh A, Garcia-Porrua C, Amoli M, Thomson W . Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol. 2002; 20(2):133-8. View

14.

Gonzalez-Gay M, Hajeer A, Dababneh A, Garcia-Porrua C, Mattey D, Amoli M . IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis. Clin Exp Rheumatol. 2002; 20(2):179-84. View

15.

Jacobsen S, Baslund B, Madsen H, Tvede N, Svejgaard A, Garred P . Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis. J Rheumatol. 2002; 29(10):2148-53. View

16.

Hernandez-Rodriguez J, Segarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Esteban M . Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation. 2003; 107(19):2428-34. DOI: 10.1161/01.CIR.0000066907.83923.32. View

17.

Gonzalez-Gay M, Amoli M, Garcia-Porrua C, Ollier W . Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003; 33(1):38-48. DOI: 10.1053/sarh.2002.50025. View

18.

Farrell R, Kelleher D . Glucocorticoid resistance in inflammatory bowel disease. J Endocrinol. 2003; 178(3):339-46. DOI: 10.1677/joe.0.1780339. View

19.

Boiardi L, Casali B, Nicoli D, Farnetti E, Chen Q, Macchioni P . Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol. 2003; 30(10):2160-4. View

20.

Salvarani C, Casali B, Nicoli D, Farnetti E, Macchioni P, Catanoso M . Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum. 2003; 48(11):3219-23. DOI: 10.1002/art.11307. View